Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
G. Nicoletti, G. Schito, G. Fadda, S. Boros, D. Nicolosi, A. Marchese, T. Spanu, A. Pantosti, M. Monaco, G. Rezza, A. Cassone & E. Garaci. (2006) Bacterial Isolates from Severe Infections and Their Antibiotic Susceptibility Patterns in Italy: a Nationwide Study in the Hospital Setting. Journal of Chemotherapy 18:6, pages 589-602.
Read now
Read now
N. Al sweih, E. Mokaddas, W. Jamal, O.A. Phillips & V.O. Rotimi. (2005)
In Vitro Activity of Linezolid and Other Antibiotics Against Gram-Positive Bacteria from the Major Teaching Hospitals in Kuwait. Journal of Chemotherapy 17:6, pages 607-613.
Read now
Read now
Articles from other publishers (4)
Paul R. Rhomberg & Ronald N. Jones. (2009) Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008). Diagnostic Microbiology and Infectious Disease 65:4, pages 414-426.
Crossref
Crossref
Sujata M. Bhavnani & Glenn S. Tillotson. 2007. Antimicrobial Resistance: Problem Pathogens and Clinical Countermeasures. Antimicrobial Resistance: Problem Pathogens and Clinical Countermeasures
25
38
.
Paul R. Rhomberg, Lalitagauri M. Deshpande, Jeffrey T. Kirby & Ronald N. Jones. (2007) Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006). Diagnostic Microbiology and Infectious Disease 59:4, pages 425-432.
Crossref
Crossref
Paul R. Rhomberg & Ronald N. Jones. (2007) Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005). Diagnostic Microbiology and Infectious Disease 57:2, pages 207-215.
Crossref
Crossref